Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji Maeda

Showing results (231-240 of 233) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 233 results.
Research Square|March 2, 2022
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2Yoshihiro Kawaoka, Ryuta Uraki, Maki Kiso, et al.
Nature|May 16, 2022
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2Ryuta Uraki, Maki Kiso, Shun Iida, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 18, 2021
Characterization of a new SARS-CoV-2 variant that emerged in BrazilMasaki Imai, Peter J Halfmann, Seiya Yamayoshi, et al.
Pageof 24

Showing results (231-240 of 233) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 233 results.
Research Square|March 2, 2022
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2Yoshihiro Kawaoka, Ryuta Uraki, Maki Kiso, et al.
Nature|May 16, 2022
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2Ryuta Uraki, Maki Kiso, Shun Iida, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 18, 2021
Characterization of a new SARS-CoV-2 variant that emerged in BrazilMasaki Imai, Peter J Halfmann, Seiya Yamayoshi, et al.
Pageof 24